183 related articles for article (PubMed ID: 27513792)
1. Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis?
Benjamin S; Warwick D
Ann R Coll Surg Engl; 2016 Nov; 98(8):538-542. PubMed ID: 27513792
[TBL] [Abstract][Full Text] [Related]
2. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
4. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
5. Does the publication of NICE guidelines for venous thromboembolism chemical prophylaxis influence the prescribing patterns of UK hip and knee surgeons?
Matharu GS; Blom AW; Board T; Whitehouse MR;
Ann R Coll Surg Engl; 2022 Mar; 104(3):195-201. PubMed ID: 34825570
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Prophylaxis for Venous Thromboembolism Among Patients With Total Joint Replacement: An Electronic Medical Records Study.
Rosenman M; Liu X; Phatak H; Qi R; Teal E; Nisi D; Liu LZ; Parr JA
Am J Ther; 2016; 23(2):e336-44. PubMed ID: 26736015
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes in patients at risk for venous thromboembolism following total knee and total hip replacement: implications for managed care.
Navarro RP; Barr JE; Faubus K; Sabharwal AD; Stern E; Unger K
Am J Manag Care; 2011 Jul; 17 Suppl 9():S251-8. PubMed ID: 21819165
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST
Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
[TBL] [Abstract][Full Text] [Related]
9. Observational study of dabigatran etexilate 150mg in patients with moderate renal impairment undergoing elective total hip or knee replacement.
Samama CM; Rosencher N; Kleine E; Feuring M; Brueckmann M; Clemens A; Gullberg J; Frostick SP
Thromb Res; 2016 Jul; 143():103-10. PubMed ID: 27208980
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
11. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
12. Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
Veettil SK; Harris J; Syeed MS; Thakkinstian A; Chaikledkaew U; Witt DM; Chaiyakunapruk N
Thromb Res; 2022 Aug; 216():74-83. PubMed ID: 35753113
[TBL] [Abstract][Full Text] [Related]
13. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice.
Pedersen AB; Mehnert F; Sorensen HT; Emmeluth C; Overgaard S; Johnsen SP
Bone Joint J; 2014 Apr; 96-B(4):479-85. PubMed ID: 24692614
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological thromboprophylaxis and total hip or knee replacement.
Frostick S
Br J Nurs; 2016 Jan 14-27; 25(1):45-53. PubMed ID: 26768045
[TBL] [Abstract][Full Text] [Related]
15. Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement.
Lalmohamed A; Vestergaard P; Jansen PA; Grove EL; de Boer A; Leufkens HG; van Staa TP; de Vries F
J Thromb Haemost; 2013 Apr; 11(4):642-50. PubMed ID: 23387806
[TBL] [Abstract][Full Text] [Related]
16. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
17. Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review.
Brockbank J; Wolowacz S
Pharmacoeconomics; 2017 May; 35(5):517-535. PubMed ID: 28185212
[TBL] [Abstract][Full Text] [Related]
18. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Nieto JA; Espada NG; Merino RG; González TC
Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
